These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16263095)

  • 1. Normal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington's disease.
    Meier A; Mollenhauer B; Cohrs S; Rodenbeck A; Jordan W; Meller J; Otto M
    Brain Res; 2005 Nov; 1063(2):201-3. PubMed ID: 16263095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid hypocretin-1 levels in multiple system atrophy.
    Martinez-Rodriguez JE; Seppi K; Cardozo A; Iranzo A; Stampfer-Kountchev M; Wenning G; Tolosa E; Högl B; Santamaria J; Poewe W;
    Mov Disord; 2007 Sep; 22(12):1822-4. PubMed ID: 17659646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration.
    Yasui K; Inoue Y; Kanbayashi T; Nomura T; Kusumi M; Nakashima K
    J Neurol Sci; 2006 Dec; 250(1-2):120-3. PubMed ID: 17005202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypocretin-1 (orexin A) levels are normal in Huntington's disease.
    Baumann CR; Hersberger M; Bassetti CL
    J Neurol; 2006 Sep; 253(9):1232-3. PubMed ID: 16598614
    [No Abstract]   [Full Text] [Related]  

  • 5. CSF hypocretin-1 levels are normal in patients with amyotrophic lateral sclerosis.
    Van Rooij FG; Schelhaas HJ; Lammers GJ; Verbeek MM; Overeem S
    Amyotroph Lateral Scler; 2009; 10(5-6):487-9. PubMed ID: 19922146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal cerebrospinal fluid levels of hypocretin-1 (orexin A) in patients with fibromyalgia syndrome.
    Taiwo OB; Russell IJ; Mignot E; Lin L; Michalek JE; Haynes W; Xiao Y; Zeitzer JM; Larson AA
    Sleep Med; 2007 Apr; 8(3):260-5. PubMed ID: 17369087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF orexin-A/hypocretin-1 concentrations in patients with intracerebral hemorrhage (ICH).
    Dohi K; Ripley B; Fujiki N; Ohtaki H; Yamamoto T; Goto Y; Nakamachi T; Shioda S; Aruga T; Nishino S
    Regul Pept; 2008 Jan; 145(1-3):60-4. PubMed ID: 17868933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypocretin-1 and secondary signs in Huntington's disease.
    Roos RA; Aziz NA
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S387-90. PubMed ID: 18267269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased cerebrospinal fluid hypocretin-1 (orexin A) in patients after repetitive generalized tonic-clonic seizures.
    Rejdak K; Papuć E; Grieb P; Stelmasiak Z
    Epilepsia; 2009 Jun; 50(6):1641-4. PubMed ID: 19175390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF hypocretin levels are normal in Huntington's disease patients.
    Gaus SE; Lin L; Mignot E
    Sleep; 2005 Dec; 28(12):1607-8. PubMed ID: 16408421
    [No Abstract]   [Full Text] [Related]  

  • 11. CSF hypocretin-1/orexin-A concentrations in patients with subarachnoid hemorrhage (SAH).
    Dohi K; Ripley B; Fujiki N; Ohtaki H; Shioda S; Aruga T; Nishino S
    Peptides; 2005 Nov; 26(11):2339-43. PubMed ID: 15893406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypocretin (orexin) loss in Alzheimer's disease.
    Fronczek R; van Geest S; Frölich M; Overeem S; Roelandse FW; Lammers GJ; Swaab DF
    Neurobiol Aging; 2012 Aug; 33(8):1642-50. PubMed ID: 21546124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF hypocretin-1 levels are normal in multiple-system atrophy.
    Abdo WF; Bloem BR; Kremer HP; Lammers GJ; Verbeek MM; Overeem S
    Parkinsonism Relat Disord; 2008; 14(4):342-4. PubMed ID: 17977056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid hypocretin-1 levels during the active period of cluster headache.
    Cevoli S; Pizza F; Grimaldi D; Nicodemo M; Favoni V; Pierangeli G; Valko PO; Baumann CR; Montagna P; Bassetti CL; Cortelli P
    Cephalalgia; 2011 Jun; 31(8):973-6. PubMed ID: 21444644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypocretin (orexin) loss in Parkinson's disease.
    Fronczek R; Overeem S; Lee SY; Hegeman IM; van Pelt J; van Duinen SG; Lammers GJ; Swaab DF
    Brain; 2007 Jun; 130(Pt 6):1577-85. PubMed ID: 17470494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A patient with anti-aquaporin 4 antibody who presented with recurrent hypersomnia, reduced orexin (hypocretin) level, and symmetrical hypothalamic lesions.
    Nozaki H; Shimohata T; Kanbayashi T; Sagawa Y; Katada S; Satoh M; Onodera O; Tanaka K; Nishizawa M
    Sleep Med; 2009 Feb; 10(2):253-5. PubMed ID: 18226957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington disease.
    Björkqvist M; Petersén A; Nielsen J; Ecker D; Mulder H; Hayden MR; Landwehrmeyer B; Brundin P; Leavitt BR
    Clin Genet; 2006 Jul; 70(1):78-9. PubMed ID: 16813610
    [No Abstract]   [Full Text] [Related]  

  • 18. Cerebrospinal fluid levels of quinolinic acid in Huntington's disease and schizophrenia.
    Schwarcz R; Tamminga CA; Kurlan R; Shoulson I
    Ann Neurol; 1988 Oct; 24(4):580-2. PubMed ID: 2977086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease comorbid with narcolepsy presenting low CSF hypocretin/orexin level.
    Maeda T; Nagata K; Kondo H; Kanbayashi T
    Sleep Med; 2006 Dec; 7(8):662. PubMed ID: 17097921
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypocretin-1 (orexin-A) concentrations in cerebrospinal fluid are low in patients with Guillain-Barré syndrome.
    Kanbayashi T; Ishiguro H; Aizawa R; Saito Y; Ogawa Y; Abe M; Hirota K; Nishino S; Shimizu T
    Psychiatry Clin Neurosci; 2002 Jun; 56(3):273-4. PubMed ID: 12047592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.